Skip to main content
Clinical Trials/NCT06711874
NCT06711874
Active, not recruiting
Not Applicable

Clinical Deterioration Caused by Elevated Parathyroid Hormone Levels Among Critically-Ill Patients With Vitamin D Depletion: a Secondary Analysis of a Multicenter, Prospective, Observational Study

National Taiwan University Hospital1 site in 1 country320 target enrollmentStarted: May 21, 2024Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
320
Locations
1
Primary Endpoint
Mortality

Overview

Brief Summary

This study aims to investigate the impacts of abnormally elevated PTH levels on clinical outcomes among critically ill patients with vitamin D depletion.

Detailed Description

This study is a secondary analysis of data from a previous multicentre, prospective, observational cohort study (REC No: 201805087RINB) examining vitamin D deficiency prevalence and outcomes in critical care. From the previously enrolled 651 critically ill patients admitted to medical and surgical intensive care units (ICUs), those enrolled within 48 hours of admission are analyzed. Vitamin D depletion is defined as a serum 25-hydroxyvitamin D (25(OH)D) level <30 ng/mL. Patients are categorized as PTH non-responders (PTH levels of 15-68.3 pg/mL) or PTH responders (PTH levels > 68.3 pg/mL). The primary endpoints include the rate of survival to day 28 and the rate of survival to hospital discharge. Secondary endpoints include the length of ICU stay at day 28 and day 90, Acute Physiology and Chronic Health Evaluation (APACHE) II score, Sequential Organ Failure Assessment (SOFA) score, and blood clinical laboratory variables.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Mortality

Time Frame: From enrollment to day 90

Survival on day 28, survival to hospital discharge

Secondary Outcomes

  • Acute Physiology and Chronic Health Evaluation II (APACHE II) score(From enrollment to day 90)
  • Sequential Organ Failure Assessment (SOFA) score(From enrollment to day 90)
  • ICU length of stay(From enrollment to day 90)
  • Laboratory parameters(From enrollment to day 90)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials